NSC Biotech Opportunities Fund, LLC — Form D
NSC Biotech Opportunities Fund, LLC of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2018-03-12. The offering totals $30.0M, of which $1.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2018-03-12
- Form: D
- Accession: 0001733796-18-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $30.0M
- Amount sold: $1.1M
- Remaining: $28.9M
- Minimum investment: $100K
- Investors: 11
- Date of first sale: 2018-02-28
- Security types: fund interests
- SEC file number: 021-307417
Issuer
- Name: NSC Biotech Opportunities Fund, LLC
- CIK: 0001733796
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 200 VESEY STREET, NEW YORK, NY, 10281
- Phone: 212-417-8150
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Tom Kowalczyk | Director | NEW YORK, NY |
| Michael Mullen | Director | NEW YORK, NY |
| n/a NSC Biotech Opportunities Management Associates, LLC | Director | New York, NY |
| Glenn Worman | Director | New York, NY |
More